Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kuo-Tung Hung, Shih-Cheng Yang, Cheng-Kun Wu, Hsing-Ming Wang, Chih-Chien Yao, Chih-Ming Liang, Wei-Chen Tai, Keng-Liang Wu, Yuan-Hung Kuo, Chen-Hsiang Lee & Seng-Kee Chuah. (2021) Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice. Infection and Drug Resistance 14, pages 1239-1246.
Read now
Read now
A. Ruigómez, S. Johansson, P. Nagy & L. A. García Rodríguez. (2017) Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study. Current Medical Research and Opinion 33:12, pages 2201-2209.
Read now
Read now
David A. Peura, Barry Traxler, Christopher Kocun & Tore Lind. (2014) Esomeprazole Treatment of Frequent Heartburn: Two Randomized, Double-Blind, Placebo-Controlled Trials. Postgraduate Medicine 126:4, pages 33-41.
Read now
Read now
Consuelo L Saccar. (2009) The pharmacology of esomeprazole and its role in gastric acid related diseases. Expert Opinion on Drug Metabolism & Toxicology 5:9, pages 1113-1124.
Read now
Read now
Articles from other publishers (16)
Fernando Sierra-Arango, D. M. Castaño, Jennifer D. Forero, Erika D. Pérez-Riveros, Gerardo Ardila Duarte, Maria L. Botero, Andres Cárdenas & Jose De la Hoz-Valle. (2019)
A Randomized Placebo-Controlled
N
-of-1 Trial: The Effect of Proton Pump Inhibitor in the Management of Gastroesophageal Reflux Disease
. Canadian Journal of Gastroenterology and Hepatology 2019, pages 1-9.
Crossref
Crossref
Kwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, Hye‐Kyung Jung, Hwoon‐Yong Jung, Il‐Kwun Chung, In‐Kyung Sung, Jin Il Kim, Jong Hyeok Kim, Joon Seong Lee, Joong Goo Kwon, Jung Ho Park, Kyu Chan Huh, Kyung Sik Park, Moo‐In Park, Nayoung Kim, Oh Young Lee, Sam Ryong Jee, Sang Kil Lee, Sei Jin Youn, Sung Kook Kim, Soo Teik Lee, Su Jin Hong, Suck Chei Choi, Tae Nyeun Kim, Young Hoon Youn, Hyo Ju Park, Min Ja Kang, Chi Hye Park, Bong Tae Kim, Sangjun Youn, Geun Seog Song & Poong‐Lyul Rhee. (2019) Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis. Alimentary Pharmacology & Therapeutics 49:7, pages 864-872.
Crossref
Crossref
Philip B. Miner, David A. Johnson, Philip O. Katz, Jing Li, Sergio C. Gatoulis & Charles Pollack. (2018) Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment. Advances in Therapy 35:11, pages 2024-2040.
Crossref
Crossref
David Y. Graham & Aylin Tansel. (2018) Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clinical Gastroenterology and Hepatology 16:6, pages 800-808.e7.
Crossref
Crossref
Jan G. Hatlebakk, Frank Zerbib, Stanislas Bruley des Varannes, Stephen E. Attwood, Christian Ell, Roberto Fiocca, Jean-Paul Galmiche, Stefan Eklund, Göran Långström, Tore Lind & Lars R. Lundell. (2016) Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy. Clinical Gastroenterology and Hepatology 14:5, pages 678-685.e3.
Crossref
Crossref
Philip Katz, Peter J. Kahrilas, David A. Johnson, Tore Lind, Kerstin Röhss, Barry Traxler, Vincent Hugo & John Dent. (2015)
Daytime intragastric acid control:
post hoc
analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors
. Therapeutic Advances in Gastroenterology 8:6, pages 322-330.
Crossref
Crossref
Helen F. Boardman & Gordon Heeley. (2015) The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. International Journal of Clinical Pharmacy 37:5, pages 709-716.
Crossref
Crossref
J. Labenz, D. Armstrong, A. Leodolter & I. Baldycheva. (2015) Management of reflux esophagitis: does the choice of proton pump inhibitor matter?. International Journal of Clinical Practice 69:7, pages 796-801.
Crossref
Crossref
Philip Katz, John Dent, Peter Kahrilas, Barry Traxler, Tore Lind, Kerstin Rohss & David Johnson. (2013) Daytime Intragastric pH With Esomeprazole 20 mg: New Comparative Analyses With Other Proton Pump Inhibitors Omeprazole 20 mg, Lansoprazole 15 mg, and Pantoprazole 20 mg. American Journal of Gastroenterology 108, pages S50.
Crossref
Crossref
Philip Katz, John Dent, David Johnson, Barry Traxler, Kerstin Rohss, Tore Lind & Peter Kahrilas. (2013) New Analyses of Daytime Acid Control with Esomeprazole 20 mg. American Journal of Gastroenterology 108, pages S41.
Crossref
Crossref
P. MinerJrJr, J. Plachetka, E. Orlemans, J. G. Fort & M. Sostek. (2010) Clinical trial: evaluation of gastric acid suppression with three doses of immediate‐release esomeprazole in the fixed‐dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric‐coated esomeprazole 20 mg: a randomized, open‐label, Phase I study in healthy volunteers. Alimentary Pharmacology & Therapeutics 32:3, pages 414-424.
Crossref
Crossref
David A. Johnson, Philip O. Katz, Doug Levine, Kerstin Röhss, Magnus Åstrand, Ola Junghard & Péter Nagy. (2010) Prevention of Relapse of Healed Reflux Esophagitis is Related to the Duration of Intragastric pH>4. Journal of Clinical Gastroenterology 44:7, pages 475-478.
Crossref
Crossref
B. Al-Judaibi, N. Chande, G.K. DresserN. SultanJ.C. Gregor. (2010) Gastric Acid-Related Diseases: Focus on Esomeprazole. Clinical Medicine Insights: Therapeutics 2, pages CMT.S4500.
Crossref
Crossref
R. Jones & T. Patrikios. (2008) The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor. International Journal of Clinical Practice 62:12, pages 1844-1850.
Crossref
Crossref
Clive Wilder-Smith, Anna Backlund, Göran Eckerwall, Tore Lind, Mia Fjellman & Kerstin Röhss. (2008) Effect of Increasing Esomeprazole and Pantoprazole Doses on Acid Control in Patients with Symptoms of Gastro-Oesophageal Reflux Disease. Clinical Drug Investigation 28:6, pages 333-343.
Crossref
Crossref
Kate McKeage, Stephanie K A Blick, Jamie D Croxtall, Katherine A Lyseng-Williamson & Gillian M Keating. (2008) Esomeprazole. Drugs 68:11, pages 1571-1607.
Crossref
Crossref